Beta Bionics, Inc.
BBNX
$19.09
-$0.40-2.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | |||
|---|---|---|---|---|---|
| Revenue | 36.39% | 144.79% | 440.09% | ||
| Total Other Revenue | -- | -- | -- | ||
| Total Revenue | 36.39% | 144.79% | 440.09% | ||
| Cost of Revenue | 51.22% | 166.15% | 317.08% | ||
| Gross Profit | 24.58% | 130.92% | 627.67% | ||
| SG&A Expenses | 79.18% | 72.95% | 139.72% | ||
| Depreciation & Amortization | -- | -- | -- | ||
| Other Operating Expenses | -- | -- | -- | ||
| Total Operating Expenses | 62.07% | 100.26% | 133.11% | ||
| Operating Income | -97.21% | -55.81% | -24.99% | ||
| Income Before Tax | -130.19% | 3.93% | -12.17% | ||
| Income Tax Expenses | -- | -- | -- | ||
| Earnings from Continuing Operations | -130.19% | 3.93% | -12.17% | ||
| Earnings from Discontinued Operations | -- | -- | -- | ||
| Extraordinary Item & Accounting Change | -- | -- | -- | ||
| Minority Interest in Earnings | -- | -- | -- | ||
| Net Income | -130.19% | 3.93% | -12.17% | ||
| EBIT | -97.21% | -55.81% | -24.99% | ||
| EBITDA | -100.08% | -58.58% | -25.97% | ||
| EPS Basic | 54.87% | 13.12% | 9.35% | ||
| Normalized Basic EPS | 54.87% | 13.12% | 9.35% | ||
| EPS Diluted | 54.87% | 13.12% | 9.35% | ||
| Normalized Diluted EPS | 54.87% | 13.12% | 9.35% | ||
| Average Basic Shares Outstanding | 410.05% | 10.59% | 23.74% | ||
| Average Diluted Shares Outstanding | 410.05% | 10.59% | 23.74% | ||
| Dividend Per Share | -- | -- | -- | ||
| Payout Ratio | -- | -- | -- | ||